Diagnosis, screening and management of cystic fibrosis related diabetes mellitus

Diabetes Research and Clinical Practice - Tập 45 Số 1 - Trang 61-73 - 1999
A. Moran1, Dana S. Hardin, David M. Rodman, Holley F. Allen, Robert J. Beall, Drucy Borowitz, Carol Brunzell, PeterE. Campbell, Sarah E. Chesrown, C. Duchow, Robert Fink, Stacey C. FitzSimmons, N. Hamilton, Irl B. Hirsch, Michelle Howenstine, David J. Klein, Zuhayr T. Madhun, Paul B. Pencharz, Alexandra L. Quittner, Mu K, Robbins, T. Schindler, Kathleen Schissel, Sarah Jane Schwarzenberg2, Virginia A. Stallings, D. Elizabeth Tullis, W.B. Zipf
1University of Minnesota
2Pediatrics - Gastro, Hepatology, Nutrition

Tóm tắt

Từ khóa


Tài liệu tham khảo

FitzSimmons, 1993, The changing epidemiology of cystic fibrosis, J. Pediatr., 122, 1, 10.1016/S0022-3476(05)83478-X

Cystic Fibrosis Foundation Patient Registry, 1997 Annual Data Report, Bethesda, MD, 1998.

Rosenecker, 1995, Genetic determination of diabetes mellitus in patients with cystic fibrosis, J. Pediatr., 127, 441, 10.1016/S0022-3476(95)70080-3

Lanng, 1994, Diabetes mellitus in Danish CF patients: prevalence and late diabetic complications, Acta Paediatr., 83, 72, 10.1111/j.1651-2227.1994.tb12956.x

Moran, 1998, Abnormal glucose metabolism in cystic fibrosis, J. Pediatr., 133, 10, 10.1016/S0022-3476(98)70171-4

Finkelstein, 1988, Diabetes mellitus associated with cystic fibrosis, J. Pediatr., 112, 373, 10.1016/S0022-3476(88)80315-9

Lanng, 1994, Diabetes mellitus in cystic fibrosis: effect of insulin therapy on lung function and infections, Acta Paediatr., 83, 849, 10.1111/j.1651-2227.1994.tb13156.x

Lanng, 1992, Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis, Eur. J. Pediatr., 151, 684, 10.1007/BF01957574

Miller, 1982, Altered body composition and muscle protein degradation in nutritionally growth-retarded children with cystic fibrosis, Am. J. Clin. Nutr., 36, 492, 10.1093/ajcn/36.3.492

Steinkamp, 1994, Improvement of nutritional status and lung function after long-term nocturnal gastrostomy feedings in cystic fibrosis, J. Pediatr., 124, 244, 10.1016/S0022-3476(94)70312-4

Hardin, 1998, Proteolysis associated with insulin resistance in cystic fibrosis, Pediatrics, 101, 433, 10.1542/peds.101.3.433

Sandler, 1988, Is the lung a ‘target organ’ in diabetes mellitus?, Arch. Intern. Med., 150, 1385, 10.1001/archinte.150.7.1385

Niranjan, 1997, Glycemic control and cardiopulmonary function in patients with insulin-dependent diabetes mellitus, Am. J. Med., 103, 504, 10.1016/S0002-9343(97)00251-9

Geffner, 1988, Role of autoimmunity in insulinopenia and carbohydrate derangements with cystic fibrosis, J. Pediatr., 112, 419, 10.1016/S0022-3476(88)80324-X

De Luca, 1991, Insulin secretion, glycosylated haemoglobin and islet cell antibodies in cystic fibrosis children and adolescents with different degrees of glucose tolerance, Horm. Metab. Res., 23, 495, 10.1055/s-2007-1003737

Lanng, 1993, Diabetes mellitus in cystic fibrosis: genetic and immunological markers, Acta Paediatr., 82, 150, 10.1111/j.1651-2227.1993.tb12628.x

Stewart, 1997, Glucose tolerance in adults with CF: phenotype-genotype correlations, Pediatr. Pulmonol. Suppl., 14, 361A

Sullivan, 1989, Diabetic microangiopathy in patients with cystic fibrosis, Pediatrics, 84, 642, 10.1542/peds.84.4.642

Rodman, 1986, The interaction of two diseases: diabetes mellitus and cystic fibrosis, Medicine, 65, 389, 10.1097/00005792-198611000-00004

Stewart, 1997, Lipid metabolism in adults with CF, Pediatr. Pulmonol. Suppl., 14, 366A

Schlesinger, 1997, Generalized atherosclerosis in an adult with CF and diabetes mellitus, Pediatr. Pulmonol. Suppl., 14, 365A

Moran, 1991, Pancreatic endocrine function in cystic fibrosis, J. Pediatr., 118, 715, 10.1016/S0022-3476(05)80032-0

Lippe, 1977, Pancreatic alpha and beta cell function in cystic fibrosis, J. Pediatr., 90, 751, 10.1016/S0022-3476(77)81241-9

Lanng, 1993, Pancreas and gut hormone responses to oral glucose and intravenous glucagon in cystic fibrosis patients with normal, impaired, and diabetic glucose tolerance, Acta Endocrinol., 128, 207, 10.1530/acta.0.1280207

Cucinotta, 1990, Beta cell function, peripheral sensitivity to insulin and islet cell autoimmunity in cystic fibrosis patients with normal glucose tolerance, Horm. Res., 34, 33, 10.1159/000181792

DeSchepper, 1992, First-phase insulin release in adult cystic fibrosis patients: correlation with clinical and biological parameters, Horm. Res., 38, 260, 10.1159/000182555

Meacham, 1991, Selective preservation of somatostatin secretion in CF patients with diabetes, Pediatr. Pulmonol. Suppl., 6, 333A

Lohr, 1989, CF associated islet changes may provide a basis for diabetes, Virchows Arch. A Pathol. Anat., 414, 179, 10.1007/BF00718598

Kopito, 1976, The pancreas in CF: chemical composition and comparative morphology, Pediatr. Res., 10, 742, 10.1203/00006450-197610080-00010

Iannucci, 1984, Endocrine pancreas in cystic fibrosis: an immunohistochemical study, Hum. Pathol., 15, 278, 10.1016/S0046-8177(84)80191-4

Couce, 1996, Diabetes mellitus in CF is characterized by islet amyloidosis, J. Clin. Endocrinol. Metab., 81, 1267, 10.1210/jc.81.3.1267

Johnson, 1989, Islet amyloid, islet-amyloid polypeptide, and diabetes mellitus, New Engl. J. Med., 321, 513, 10.1056/NEJM198908243210806

Laszik, 1989, Endocrine pancreas in chronic pancreatitis, Arch. Pathol. Lab. Med., 113, 47

Clark, 1987, Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes, Lancet, 2, 231, 10.1016/S0140-6736(87)90825-7

Lorenzo, 1994, Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus, Nature, 368, 756, 10.1038/368756a0

Moran, 1994, Insulin sensitivity in cystic fibrosis, Diabetes, 43, 1020, 10.2337/diabetes.43.8.1020

Holl, 1995, Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycemia in CF, Eur. J. Pediatr., 154, 356, 10.1007/BF02072102

Austin, 1994, Roles of insulin resistance and β-cell dysfunction in the pathogenesis of glucose intolerance in cystic fibrosis, J. Clin. Endocrinol. Metab., 79, 80, 10.1210/jc.79.1.80

Hardin, 1997, Insulin resistance is associated with decreased clinical status in cystic fibrosis, J. Pediatr., 130, 948, 10.1016/S0022-3476(97)70282-8

Lanng, 1994, Insulin sensitivity and insulin clearance in CF patients with normal and diabetic glucose tolerance, Clin. Endocrinol., 41, 217, 10.1111/j.1365-2265.1994.tb02533.x

Ahmad, 1994, Insulin sensitivity and metabolic clearance rate of insulin in cystic fibrosis, Metabolism, 43, 163, 10.1016/0026-0495(94)90239-9

1998, Clinical practice recommendations, Diabetes Care, S1

1997, Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, Diabetes Care, 20, 1183, 10.2337/diacare.20.7.1183

Allen, 1998, Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the U.S., Diabetes Care, 21, 943, 10.2337/diacare.21.6.943

McCance, 1994, Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes, Br. Med. J., 308, 1323, 10.1136/bmj.308.6940.1323

Engelgau, 1997, Comparison of fasting and 2-hour glucose and hemoglobin A1c levels for diagnosing diabetes: diagnostic criteria and performance revisited, Diabetes Care, 20, 785, 10.2337/diacare.20.5.785

Lanng, 1995, Glucose tolerance in cystic fibrosis: a five year prospective study, Br. Med. J., 311, 655, 10.1136/bmj.311.7006.655

DeSchepper, 1991, Oral glucose tolerance testing in cystic fibrosis: correlations with clinical parameters and glycosylated hemoglobin determinations, Eur. J. Pediatr., 150, 403, 10.1007/BF02093718

De Luca, 1995, Four-year follow-up of glucose tolerance and beta-cell function in nondiabetic CF patients, Horm. Res., 44, 45, 10.1159/000184591

Bertele-Harms, 1996, Sulfonylurea in the treatment of CFRD. A 15 year experience, Pediatr. Pulmonol., 13, 380A

Culler, F.L., McKean, L.P., Buchanan, C.J., Caplan, D.B., Meacham, L.R., Glipizide treatment of patients with CF and impaired glucose tolerance, Endocrine Society Program and Abstracts, San Antonio, TX, 1992, 45A.

Hinds, 1995, Tobutamide causes a modest increase in insulin secretion in CF patients with impaired glucose tolerance, Metab. Clin. Exp., 44, 13, 10.1016/0026-0495(95)90283-X

Horswill, 1990, Glipizide increased insulin secretion but not growth of children with CF, FASEB J., 4, 3272A

Zipf, 1991, Effects of tolbutamide on growth and body composition of nondiabetic children with CF, Pediatr. Res., 30, 309, 10.1203/00006450-199110000-00004

Sheppard, 1992, Effect of ATP-sensitive K+ channel regulators on cystic fibrosis transmembrane conductance regulator chloride currents, J. Gen. Physiol., 100, 573, 10.1085/jgp.100.4.573

Ramsey, 1992, Nutritional assessment and management in cystic fibrosis: a consensus report, Am. J. Clin. Nutr., 55, 71, 10.1093/ajcn/55.1.108

Kraemer, 1978, Relative underweight in cystic fibrosis and its prognostic value, Acta Paediatr. Scand., 67, 33, 10.1111/j.1651-2227.1978.tb16273.x

FitzSimmons, 1996, A longitudinal sudy of the effects of pregnancy on 325 women with CF, Pediatr. Pulmonol., 13, 99

La Greca, 1995, Adherence to prescribed medical regiments, 55

Johnson, 1995, Insulin-dependent diabetes mellitus in childhood, 263